GB201003936D0 - Novel inhibitors - Google Patents

Novel inhibitors

Info

Publication number
GB201003936D0
GB201003936D0 GBGB1003936.0A GB201003936A GB201003936D0 GB 201003936 D0 GB201003936 D0 GB 201003936D0 GB 201003936 A GB201003936 A GB 201003936A GB 201003936 D0 GB201003936 D0 GB 201003936D0
Authority
GB
United Kingdom
Prior art keywords
novel inhibitors
inhibitors
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1003936.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivoryon Therapeutics AG
Original Assignee
Probiodrug AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiodrug AG filed Critical Probiodrug AG
Priority to GBGB1003936.0A priority Critical patent/GB201003936D0/en
Publication of GB201003936D0 publication Critical patent/GB201003936D0/en
Ceased legal-status Critical Current

Links

GBGB1003936.0A 2010-03-10 2010-03-10 Novel inhibitors Ceased GB201003936D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1003936.0A GB201003936D0 (en) 2010-03-10 2010-03-10 Novel inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1003936.0A GB201003936D0 (en) 2010-03-10 2010-03-10 Novel inhibitors

Publications (1)

Publication Number Publication Date
GB201003936D0 true GB201003936D0 (en) 2010-04-21

Family

ID=42136734

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1003936.0A Ceased GB201003936D0 (en) 2010-03-10 2010-03-10 Novel inhibitors

Country Status (1)

Country Link
GB (1) GB201003936D0 (en)

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2683693A4 (en) Rorgammat inhibitors
EP2566479A4 (en) Azaindazoles
EP2552208A4 (en) Imidazolyl-imidazoles as kinase inhibitors
EP2640189A4 (en) 3-deutero-pomalidomide
EP2552214A4 (en) Pyrazolyl-pyrimidines as kinase inhibitors
EP2552211A4 (en) Indazolyl-pyrimidines as kinase inhibitors
EP2568812A4 (en) Novel prolylcarboxypeptidase inhibitors
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2651505A4 (en) Electroporation-induced electrosensitization
GB201018996D0 (en) Novel ROCK inhibitors
EP2641891A4 (en) Pkc- activator
EP2571359A4 (en) Novel prolylcarboxypeptidase inhibitors
ZA201303360B (en) Kat ii inhibitors
EP2629616A4 (en) Substituted amino-triazolyl pde10 inhibitors
EP2579716A4 (en) Novel prolylcarboxypeptidase inhibitors
EP2571855A4 (en) Novel prolylcarboxypeptidase inhibitors
EP2563379A4 (en) Sox9 inhibitors
GB201018480D0 (en) Factors
HK1187611A1 (en) Kat ii inhibitors kat ii
EP2579873A4 (en) Novel prolylcarboxypeptidase inhibitors
GB201006605D0 (en) Novel inhibitors
GB201003936D0 (en) Novel inhibitors
GB201003502D0 (en) Novel inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)